Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
Clinical trial NCT06959550 · RECRUITING
Trial details
- NCT number
- NCT06959550
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-28
- Primary completion
- 2028-07-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.